Obesity is a major component of the metabolic syndrome and has been shown to contribute directly to hepatic steatosis through mechanisms involving increased free fatty acid (FFA) flux, insulin resistance, and proinflammatory cytokine production in MASLD [20]. The gene discussed is INS; the disease is fatty liver disease.